相关实验视频

Updated: Sep 15, 2025

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

甲和脏:解剖炎症和氧化应激反应中的性别差异

Katayoon Kosari¹, Shadan Saberi², Hamid Najafipour³

¹Student Research Committee, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.

Addiction & health

|July 16, 2025

概括

甲治疗可以通过增加炎症和氧化应激来损害功能和组织,特别是在雄性大鼠中. 雌性大鼠表现出一些增加的抗氧化活性,这表明性别特异性对甲腎毒性的反应.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
药理学药理学是指药理学的学科.
毒理学毒理学毒理学

背景情况:

甲是一种合成阿片类受体激活剂,用于阿片类成治疗.
了解其对脏健康的影响对于患者管理至关重要.
性别对功能的影响需要进一步研究.

研究的目的:

调查甲对脏组织和功能的性别特异性影响.
阐明涉及炎症和氧化还原系统的机制.
评估甲对氧化应激标志物和炎症细胞因子的影响.

主要方法:

维斯塔鼠 (雄性和雌性) 被分为对照组和甲治疗组 (5 mg/kg和20 mg/kg) 进行了八周的治疗.
通过血液尿素 (BUN) 和血清肌素 (sCr) 来评估功能.
分析脏组织的炎症性细胞因子,氧化应激标记物 (甲) 和抗氧化酶活性 (氨酸过氧化酶,催化酶),以及他的病理学.

主要成果:

甲诱导组织损伤,导致炎症增加,氧化应激 (MDA升高) 和功能受损 (BUN,sCr增加).
与雌性相比,雄性大鼠表现出更严重的病理和功能障碍.
炎症标志物 (TGF-β,TNF-α,IL-17) 增加,而抗氧化酶 (GPx,Cat) 主要在女性中升高.

结论:

长时间的甲治疗具有通过氧化应激和炎症介导的毒作用.
雄性大鼠对甲诱导的损伤表现出更大的敏感性.
抗氧化剂防御中的性别差异可能会影响甲对的影响.

关键词:

性别差异的性别差异它们的IL-17是IL-17.炎症炎症是一种炎症.甲 - 毒性甲 - 毒性氧化应激是一种氧化应激.

更多相关视频

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

相关概念视频

Factors Affecting Drug Biotransformation: Biological

Factors Affecting Drug Biotransformation: Biological

Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

Acute Kidney Injury II: Pathophysiology

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...